These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Zhang J; Grindley JC; Yin T; Jayasinghe S; He XC; Ross JT; Haug JS; Rupp D; Porter-Westpfahl KS; Wiedemann LM; Wu H; Li L Nature; 2006 May; 441(7092):518-22. PubMed ID: 16633340 [TBL] [Abstract][Full Text] [Related]
5. The PI-3kinase pathway in hematopoietic stem cells and leukemia-initiating cells: a mechanistic difference between normal and cancer stem cells. Yilmaz OH; Morrison SJ Blood Cells Mol Dis; 2008; 41(1):73-6. PubMed ID: 18387833 [TBL] [Abstract][Full Text] [Related]
6. mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion. Lee JY; Nakada D; Yilmaz OH; Tothova Z; Joseph NM; Lim MS; Gilliland DG; Morrison SJ Cell Stem Cell; 2010 Nov; 7(5):593-605. PubMed ID: 21040901 [TBL] [Abstract][Full Text] [Related]
7. Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression. Magee JA; Ikenoue T; Nakada D; Lee JY; Guan KL; Morrison SJ Cell Stem Cell; 2012 Sep; 11(3):415-28. PubMed ID: 22958933 [TBL] [Abstract][Full Text] [Related]
9. PTEN takes center stage in cancer stem cell research, works as tumor suppressor. Hede K J Natl Cancer Inst; 2006 Jun; 98(12):808-9. PubMed ID: 16788153 [No Abstract] [Full Text] [Related]
10. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Krivtsov AV; Twomey D; Feng Z; Stubbs MC; Wang Y; Faber J; Levine JE; Wang J; Hahn WC; Gilliland DG; Golub TR; Armstrong SA Nature; 2006 Aug; 442(7104):818-22. PubMed ID: 16862118 [TBL] [Abstract][Full Text] [Related]
11. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nakada D; Saunders TL; Morrison SJ Nature; 2010 Dec; 468(7324):653-8. PubMed ID: 21124450 [TBL] [Abstract][Full Text] [Related]
17. mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis. Kalaitzidis D; Sykes SM; Wang Z; Punt N; Tang Y; Ragu C; Sinha AU; Lane SW; Souza AL; Clish CB; Anastasiou D; Gilliland DG; Scadden DT; Guertin DA; Armstrong SA Cell Stem Cell; 2012 Sep; 11(3):429-39. PubMed ID: 22958934 [TBL] [Abstract][Full Text] [Related]
18. A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancer-initiating cell. Ito K; Bernardi R; Pandolfi PP Curr Opin Genet Dev; 2009 Feb; 19(1):51-9. PubMed ID: 19216069 [TBL] [Abstract][Full Text] [Related]
19. Small molecule regulation of normal and leukemic stem cells. Fares I; Rivest-Khan L; Cohen S; Sauvageau G Curr Opin Hematol; 2015 Jul; 22(4):309-16. PubMed ID: 26049751 [TBL] [Abstract][Full Text] [Related]
20. Leukaemia: niche retreats for stem cells. Williams DA; Cancelas JA Nature; 2006 Dec; 444(7121):827-8. PubMed ID: 17167463 [No Abstract] [Full Text] [Related] [Next] [New Search]